À retenir
Pooling individual patient data from 16 randomised trials (6,522 participants), self-monitoring was associated with 3.12 mm Hg lower clinic systolic pressure than usual care at 12 months (95% CI -4.78 to -1.46), regardless of how many conditions people had. Only 16 of 22 eligible trials supplied data, and gains in obesity or stroke appeared mainly with intensive extra support.
Study design
Revue des preuves
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Self-monitoring of blood pressure tends to work when paired with other supports, but people with hypertension often have other conditions too, and it was unclear whether it still helps them. The authors tested whether self-monitoring lowers clinic blood pressure in people with hypertension-related co-morbidity, and whether that depends on how many and which conditions, and on how intensive the added support was.
Population et méthode
Systematic review and one-stage individual patient data (IPD) meta-analysis of randomised controlled trials of blood pressure self-monitoring. The authors searched Medline, Embase and the Cochrane Library up to January 2018 and requested IPD. Of 22 eligible trials, 16 supplied IPD for the primary outcome, covering 6,522 participants (89%) with follow-up data. Trials were categorised in advance by whether the co-intervention was low or high intensity. Outcomes were change in clinic blood pressure and the likelihood of uncontrolled blood pressure at 12 months, analysed by the number and type of hypertension-related co-morbidity.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1At 12 months, self-monitoring was associated with 3.12 mm Hg lower clinic systolic blood pressure than usual care (95% CI -4.78 to -1.46 mm Hg), and the effect did not differ by number of co-morbidities (P for interaction = 0.260).
- 2In people with obesity, intense co-interventions were more effective than low-intensity ones (P<0.001 for all outcomes).
- 3In people with stroke, intense co-interventions possibly did better, but only for the blood pressure control outcome (P<0.004).
- 4This extra benefit from intense co-interventions was not seen in people with coronary heart disease, diabetes or chronic kidney disease.
Limites et incertitude
- 1Only 16 of the 22 eligible trials supplied individual patient data for the primary outcome, so the pooled result leaves out the rest.
- 2The abstract does not describe what the low and high-intensity co-interventions were, so it is unclear which extra supports made the difference.
- 3The outcome was clinic blood pressure at 12 months, not heart attacks, strokes or death. The condition-specific results are subgroup analyses, the stroke finding is described only as possible, and effect sizes by condition are not given. This reading is based on the abstract only.
Mise en perspective
Checking your own blood pressure was associated with lower clinic readings after a year, even among people with several other conditions. For people with obesity or a history of stroke, the benefit seemed to depend on pairing monitoring with more intensive support, so a cuff alone may not be enough. Which cuff, schedule and support suit you is a decision for your clinician.
Vos données
This is the most direct match to a home blood pressure cuff: record readings on a consistent schedule, seated and rested, and compare averages over weeks rather than single readings. The trials measured the outcome at the clinic, so bring your logged home readings to appointments and review them with your clinician, who can supply the extra support that seemed to matter for some conditions.
Comprendre ce type de preuve
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of some co-morbidities. This study examined whether self-monitoring can reduce clinic BP in patients with hypertension-related co-morbidity.
Methods
A systematic review was conducted of articles published in Medline, Embase, and the Cochrane Library up to January 2018. Randomized controlled trials of self-monitoring of BP were selected and individual patient data (IPD) were requested. Contributing studies were prospectively categorized by whether they examined a low/high-intensity co-intervention. Change in BP and likelihood of uncontrolled BP at 12 months were examined according to number and type of hypertension-related co-morbidity in a one-stage IPD meta-analysis.
Results
A total of 22 trials were eligible, 16 of which were able to provide IPD for the primary outcome, including 6,522 (89%) participants with follow-up data. Self-monitoring was associated with reduced clinic systolic BP compared to usual care at 12-month follow-up, regardless of the number of hypertension-related co-morbidities (-3.12 mm Hg, [95% confidence intervals -4.78, -1.46 mm Hg]; P value for interaction with number of morbidities = 0.260). Intense interventions were more effective than low-intensity interventions in patients with obesity (P < 0.001 for all outcomes), and possibly stroke (P < 0.004 for BP control outcome only), but this effect was not observed in patients with coronary heart disease, diabetes, or chronic kidney disease.
Conclusions
Self-monitoring lowers BP regardless of the number of hypertension-related co-morbidities, but may only be effective in conditions such obesity or stroke when combined with high-intensity co-interventions.
Sources et attribution
Self-monitoring of Blood Pressure in Patients With Hypertension-Related Multi-morbidity: Systematic Review and Individual Patient Data Meta-analysis.
Sheppard JP, Tucker KL, Davison WJ, Stevens R, Aekplakorn W, Bosworth HB, Bove A, Earle K, Godwin M, Green BB, Hebert P, Heneghan C, Hill N, Hobbs FDR, Kantola I, Kerry SM, Leiva A, Magid DJ, Mant J, Margolis KL, McKinstry B, McLaughlin MA, McNamara K, Omboni S, Ogedegbe O, Parati G, Varis J, Verberk WJ, Wakefield BJ, McManus RJ.
American journal of hypertension · 2020-03-01
DOI: 10.1093/ajh/hpz182 ↗PubMed · 31730171 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

